Accuray narrows loss

Accuray, the parent of Madison-based TomoTherapy, posted a net loss of $18.7 million (25 cents/share) on revenues of $84.9 million for its fiscal fourth quarter ending June 30. For the same period a year ago, the company reported a $20.3 million net loss on $100.5 million in revenues. For its full fiscal 2013 year, Accuray reported a net loss of $103.2 million ($1.41/share) on $316 million in revenues, compared to FY 2012’s $72 million net loss ($1.02/share) on $409.2 million in revenues.